Press release: Uppsala,
Based on the above, the Nomination committee for the 2023 Annual General Meeting (AGM) has been appointed with the following three members:
Bertil Lindkvist Tore Robertsson Arne Paalberg
The Nomination committee shall submit proposals for decisions regarding the following subjects for the AGM on
- Election of chairman at the AGM.
- Determination of number of board members.
- Determination of fees and other compensation for the board and its committees, divided between the chairman and other board members.
- Determination of fees for auditors.
- Election of board members and chairman of the board.
- Election of auditors.
- Principles for the Nomination committee's composition and work ahead of the 2024 AGM.
Shareholders who wish to submit proposals to the Nomination committee can do so via e-mail to: Eva.Sjokvist.Saers@dicot.se
In order for the Nomination committee to be able to consider proposals, the proposal must have been received in good time before the AGM, but no later than
For further information, please contact:
Tel: +46 739 80 14 08
Email: elin.trampe@dicot.se
About Dicot AB
Dicot is developing the drug candidate LIB-01, which will be a potency agent to better treat erectile dysfunction and premature ejaculation. The ambition is to create a drug with significantly longer effect and far fewer side effects, compared to those on the market. Today, at least 500 million men suffer from these sexual dysfunctions and the market is valued at
Dicot is listed on
https://news.cision.com/dicot-ab--publ-/r/the-nomination-committee-for-dicot-ab-appointed,c3660786
https://mb.cision.com/Main/17172/3660786/1648031.pdf
(c) 2022 Cision. All rights reserved., source